SK Biopharmaceuticals Submits Supplemental New Drug Application to U.S. FDA for Cenobamate
· prnewswire.com · popularity 20/100 · 0 similar stories today · Medicine & Clinical Health (Health & Life Sciences)
Read the original at prnewswire.com →
Summary
Application seeks indication for primary generalized tonic-clonic (PGTC) seizures and expansion of existing focal-onset seizure indication to pediatric patients - Submission supported by results from a global Phase 3 trial evaluating the efficacy and safety of cenobamate in patients with...
Found in: PR Newswire. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 5.